Joseph Chadwick, MD
Family Medicine · Uniontown, PANPI 1801887674
Payments from drug & device makers
Across 242 payments — averaging $15.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$546
- GSK$519
- Lilly USA, LLC$305
- Johnson & Johnson$290
- Amgen$241
- Abbott$199
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,722100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $546 |
| GSK | 42 | $519 |
| Lilly USA, LLC | 20 | $305 |
| Johnson & Johnson | 20 | $290 |
| Amgen | 12 | $241 |
| Abbott | 11 | $199 |
| Pfizer | 12 | $189 |
| Radius Health, Inc. | 3 | $156 |
| Amarin Pharma, Inc. | 9 | $155 |
| Boehringer Ingelheim | 9 | $132 |
| AstraZeneca | 8 | $116 |
| Novartis | 7 | $112 |
| Idorsia Pharmaceuticals US Inc | 4 | $84 |
| AbbVie(2 entities) | 5 | $75 |
| Sanofi-aventis U.S. LLC | 5 | $75 |
| Sunovion Pharmaceuticals Inc. | 6 | $74 |
| Akcea Therapeutics, Inc. | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Avanir Pharmaceuticals, Inc. | 3 | $43 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Eisai Inc. | 2 | $40 |
| Merck | 3 | $40 |
| Bayer | 2 | $39 |
| Genentech USA, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Boston Scientific | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Medtronic | 1 | $12 |
How this compares
$3,737 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 674 | $151,790 |
| TrulicityDulaglutide | 56 | $47,531 |
| NuplazidPimavanserin Tartrate | 18 | $44,384 |
| AustedoDeutetrabenazine | 32 | $42,179 |
| Risperidone ErRisperidone Microspheres | 32 | $33,223 |
| NuedextaDextromethorphan Hbr/Quinidine | 68 | $26,241 |
| XareltoRivaroxaban | 127 | $26,207 |
| FanaptIloperidone | 100 | $22,287 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 141 | $18,296 |
| MresviaRsv Vaccine, Pref, Mrna/Pf | 56 | $17,321 |
| VraylarCariprazine Hcl | 46 | $16,351 |
| AuvelityDextromethorphan Hbr/Bupropion | 23 | $13,588 |
| Divalproex Sodium | 516 | $13,369 |
| TradjentaLinagliptin | 69 | $12,848 |
| FarxigaDapagliflozin Propanediol | 34 | $11,906 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $189 | $151,790674 claims |
| Lilly USA, LLCTrulicity | $305 | $47,53156 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $41 | $42,17932 claims |
| Boehringer IngelheimTradjenta, Jardiance, Synjardy Xr | $132 | $28,512121 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $43 | $26,24168 claims |
| Johnson & JohnsonXarelto | $290 | $26,207127 claims |
| AbbVieVraylar, Lumigan | $75 | $20,10559 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $519 | $17,35337 claims |
| AstraZenecaFarxiga, Brilinta | $116 | $15,81652 claims |
| Novo NordiskOzempic | $546 | $11,16311 claims |
| NovartisEntresto | $112 | $10,18631 claims |
| MerckJanumet Xr | $40 | $6,05339 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Uniontown
- Richard CookUniontown$2.1M
- Joseph LabudaUniontown$812K
- Richard CookUniontown$567K
- Kenton HessUniontown$435K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.